目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Market Estimates
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for DNA Repair Drugs, by Type, Through 2026
Figure Summary : Global Market for DNA Repair Drugs, by Type, 2020-2026

Chapter- 3: Market and Technology Background
DNA Damage
Sources of DNA Damage
DNA Repair Mechanism
Repair of Double-Strand Breaks
Nucleotide Excision Repair
Mismatch Repair
Targets for Cancer Therapy
DNA Damage Response for Cancer Chemotherapy
Targeting PARP-1
Targeting APE 1
Targeting XRCC 1
Targeting DNA-PKcs
Targeting Ligases
Targeting PI-3 kinase

Chapter- 4: Market Breakdown by Technology Type
Poly(ADP-Ribose) Polymerase Inhibitors
Structure and Function of PARP Inhibitors
Use of PARP Inhibitors in Treatment
Table 1 : Global Market for DNA Repair Drugs, by Type, Through 2026
Figure 10 : Global Market for DNA Repair Drugs, by Type, 2020-2026

Chapter- 5: Market Breakdown by Application
Ovarian Cancer
Epidemiology of Ovarian Cancer
Breast Cancer
Global Impact
Table 3 : Global Market for DNA Repair Drugs, by Application, Through 2026
Figure 14 : Global Market for DNA Repair Drugs, by Application, 2020-2026

Chapter- 6: Market Breakdown by Region
Market Overview and Discussion
Rise of DNA Repair Cases by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter- 7: R&D in the Pharmaceutical Industry
Healthcare Expenditures
Continued Emphasis on R&D Activities
Trends in the Pharmaceutical Industry
Factors Influencing Spending for R&D
Trends in R&D Spending and New Drug Development
R&D Spending
New Drug Development
Approvals of New Drugs
Trends in Recent Drug Spending by Therapeutic Class
Types of New Drug Development
Factors Influencing R&D Spending
Projected Revenues
Revenues as Funding for R&D
New Drug Costs in R&D

Chapter- 8: DNA Repair Inhibitors on SARS-CoV-2
Biological Structure of SARS-CoV-2

Chapter- 9: Company Profiles
ABBVIE INC.
AMGEN INC.
ABBOTT LABORATORIES
ASTRAZENECA PLC
BAYER AG
BRISTOL-MYERS SQUIBB CO.
ELI LILLY
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
MERCK & CO., INC.
MERCK KGAA
NOVARTIS AG
PFIZER INC.
SANOFI S.A.